Nifty
:
23349.90
Sensex
:
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)
Nifty
Sensex
:
:
23349.90
77155.79
-168.60 (-0.72%)
-422.59 (-0.54%)

Unichem Laboratories Ltd.

Pharmaceuticals & Drugs - Global

Rating :
N/A

BSE: 506690 | NSE: UNICHEMLAB

NSE BSE
533.55
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  534.80
  •  538.00
  •  529.60
  •  532.65
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  12096
  •  64.57
  •  937.95
  •  400.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,059.82
  • N/A
  • 2
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 6,130.04
  • N/A
  • 2.58

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 70.22%
  • 0.45%
  • 14.58%
  • FII
  • DII
  • Others
  • 0.94%
  • 10.44%
  • 3.37%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.56
  • 9.09
  • 10.32

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -0.08
  • -
  • 6.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 2.93
  • 18.48

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.35
  • 0.96
  • 1.16

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.79
  • 27.66
  • 21.78

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Net Sales
462.16
415.63
11.20%
446.43
423.19
5.49%
431.70
402.10
7.36%
434.38
302.50
43.60%
Expenses
404.63
406.86
-0.55%
402.94
395.17
1.97%
406.35
385.62
5.38%
396.26
345.26
14.77%
EBITDA
57.53
8.77
555.99%
43.50
28.02
55.25%
25.35
16.48
53.82%
38.12
-42.76
-
EBIDTM
12.45%
2.11%
9.74%
6.62%
5.87%
4.10%
8.77%
-14.14%
Other Income
8.79
5.53
58.95%
3.86
8.63
-55.27%
6.15
5.11
20.35%
11.28
16.35
-31.01%
Interest
4.79
6.73
-28.83%
4.03
5.76
-30.03%
4.59
5.52
-16.85%
5.58
4.09
36.43%
Depreciation
28.54
29.45
-3.09%
28.33
28.77
-1.53%
27.16
29.68
-8.49%
27.86
30.78
-9.49%
PBT
32.99
-21.88
-
15.00
2.12
607.55%
-125.87
-47.16
-
83.97
-61.28
-
Tax
2.50
2.61
-4.21%
5.74
2.79
105.73%
3.44
-2.89
-
-0.02
2.65
-
PAT
30.49
-24.49
-
9.25
-0.67
-
-129.31
-44.27
-
83.99
-63.93
-
PATM
6.60%
-5.89%
2.07%
-0.16%
-29.95%
-11.01%
19.34%
-21.13%
EPS
4.33
-3.48
-
1.31
-0.09
-
-18.37
-6.29
-
11.93
-9.08
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
1,774.67
1,704.89
1,343.02
1,269.83
1,235.14
1,103.71
1,188.19
1,379.90
1,540.06
1,332.65
1,201.79
Net Sales Growth
14.98%
26.94%
5.76%
2.81%
11.91%
-7.11%
-13.89%
-10.40%
15.56%
10.89%
 
Cost Of Goods Sold
668.43
565.63
482.45
356.91
302.14
308.63
364.19
274.97
188.77
386.97
378.57
Gross Profit
1,106.24
1,139.27
860.57
912.92
933.00
795.08
823.99
1,104.93
1,351.28
945.67
823.23
GP Margin
62.33%
66.82%
64.08%
71.89%
75.54%
72.04%
69.35%
80.07%
87.74%
70.96%
68.50%
Total Expenditure
1,610.18
1,604.65
1,388.58
1,197.04
1,144.03
1,154.53
1,269.21
1,358.21
1,357.62
1,168.77
1,100.79
Power & Fuel Cost
-
107.14
102.84
78.05
68.89
73.02
76.39
49.23
41.62
38.25
39.39
% Of Sales
-
6.28%
7.66%
6.15%
5.58%
6.62%
6.43%
3.57%
2.70%
2.87%
3.28%
Employee Cost
-
393.06
356.41
330.49
306.97
273.28
238.52
200.64
169.04
255.92
223.20
% Of Sales
-
23.05%
26.54%
26.03%
24.85%
24.76%
20.07%
14.54%
10.98%
19.20%
18.57%
Manufacturing Exp.
-
227.80
194.60
193.21
215.73
232.08
147.23
125.30
103.70
150.54
145.03
% Of Sales
-
13.36%
14.49%
15.22%
17.47%
21.03%
12.39%
9.08%
6.73%
11.30%
12.07%
General & Admin Exp.
-
133.02
119.02
109.60
123.98
147.90
229.37
594.53
744.66
167.66
153.29
% Of Sales
-
7.80%
8.86%
8.63%
10.04%
13.40%
19.30%
43.09%
48.35%
12.58%
12.76%
Selling & Distn. Exp.
-
178.00
129.56
120.68
122.52
116.12
197.24
108.38
107.77
166.84
157.12
% Of Sales
-
10.44%
9.65%
9.50%
9.92%
10.52%
16.60%
7.85%
7.00%
12.52%
13.07%
Miscellaneous Exp.
-
0.00
3.70
8.11
3.81
3.50
16.26
5.16
2.06
2.58
157.12
% Of Sales
-
0%
0.28%
0.64%
0.31%
0.32%
1.37%
0.37%
0.13%
0.19%
0.35%
EBITDA
164.50
100.24
-45.56
72.79
91.11
-50.82
-81.02
21.69
182.44
163.88
101.00
EBITDA Margin
9.27%
5.88%
-3.39%
5.73%
7.38%
-4.60%
-6.82%
1.57%
11.85%
12.30%
8.40%
Other Income
30.08
31.60
38.52
47.51
50.19
91.31
98.41
3,278.19
5.50
19.11
20.72
Interest
18.99
22.66
17.31
6.11
5.12
7.85
7.52
8.01
3.36
2.90
3.04
Depreciation
111.89
113.24
113.44
91.17
84.36
81.67
67.37
50.51
43.52
38.79
41.27
PBT
6.09
-4.06
-137.80
23.03
51.82
-49.02
-57.50
3,241.36
141.07
141.31
77.41
Tax
11.66
8.81
25.86
-11.09
17.15
11.97
-33.64
696.23
32.58
29.30
2.13
Tax Rate
191.46%
-14.29%
-14.66%
-48.15%
33.10%
-24.42%
58.50%
21.48%
23.09%
21.27%
2.75%
PAT
-5.58
-70.47
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
PAT before Minority Interest
-5.58
-70.47
-202.23
33.06
34.67
-61.00
-23.87
2,545.13
108.49
108.48
75.28
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-0.31%
-4.13%
-15.06%
2.60%
2.81%
-5.53%
-2.01%
184.44%
7.04%
8.14%
6.26%
PAT Growth
0.00%
-
-
-4.64%
-
-
-
2,245.96%
0.01%
44.10%
 
EPS
-0.79
-10.01
-28.73
4.70
4.92
-8.66
-3.39
361.52
15.41
15.41
10.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
2,362.42
2,435.30
2,618.41
2,556.83
2,531.35
2,619.91
2,680.08
1,063.62
954.33
867.52
Share Capital
14.08
14.08
14.08
14.08
14.08
14.08
14.07
18.18
18.17
18.15
Total Reserves
2,345.27
2,409.18
2,593.65
2,535.00
2,512.44
2,601.99
2,665.42
1,044.00
935.01
848.52
Non-Current Liabilities
92.27
108.03
143.88
49.16
43.72
10.10
46.46
64.49
76.02
74.21
Secured Loans
38.22
63.65
89.01
0.00
0.00
0.00
0.33
0.44
22.98
20.35
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
35.80
41.91
39.96
30.41
23.51
14.60
10.76
25.33
12.58
8.88
Current Liabilities
707.88
639.60
552.13
505.76
566.73
502.92
463.51
392.62
275.09
211.76
Trade Payables
299.37
290.69
183.19
210.08
250.22
221.41
226.23
210.73
163.95
138.23
Other Current Liabilities
115.19
128.34
135.06
176.97
122.04
68.45
63.03
68.01
60.56
45.86
Short Term Borrowings
155.26
208.08
215.69
100.63
184.03
199.67
150.29
97.62
12.93
1.63
Short Term Provisions
138.06
12.50
18.19
18.09
10.44
13.39
23.97
16.25
37.65
26.05
Total Liabilities
3,162.57
3,182.93
3,314.42
3,111.75
3,141.80
3,132.93
3,190.05
1,520.73
1,305.44
1,153.49
Net Block
1,195.97
1,256.66
990.03
880.42
866.06
806.29
574.45
487.22
402.60
415.99
Gross Block
1,793.08
1,750.29
1,379.74
1,193.56
1,098.27
975.96
689.74
561.37
439.53
724.65
Accumulated Depreciation
597.10
493.63
389.70
313.14
232.21
169.67
115.29
74.15
36.92
308.66
Non Current Assets
1,465.06
1,591.06
1,666.02
1,734.44
1,455.33
1,093.64
853.59
772.27
673.34
589.07
Capital Work in Progress
122.71
147.45
493.81
567.50
330.47
92.39
238.15
249.98
237.13
122.64
Non Current Investment
0.02
0.16
0.28
159.12
134.38
129.20
9.20
9.51
5.54
5.83
Long Term Loans & Adv.
124.91
168.07
165.59
112.89
112.90
56.37
24.05
25.57
28.05
44.61
Other Non Current Assets
21.45
18.72
16.30
14.52
11.52
9.39
7.74
0.00
0.00
0.00
Current Assets
1,694.16
1,588.47
1,644.92
1,377.32
1,686.47
2,039.29
2,336.47
748.46
632.11
564.42
Current Investments
1.34
1.54
263.58
236.43
419.10
800.75
895.55
8.00
8.04
35.04
Inventories
704.68
625.23
600.22
538.34
396.54
338.66
272.86
281.71
230.57
207.68
Sundry Debtors
610.40
588.62
495.43
250.27
390.14
436.05
276.92
315.32
220.09
191.58
Cash & Bank
154.32
185.36
114.10
82.45
233.81
200.99
681.46
16.14
20.13
26.96
Other Current Assets
223.42
31.31
34.60
62.21
246.88
262.83
209.68
127.29
153.28
103.17
Short Term Loans & Adv.
194.09
156.40
136.99
207.62
183.04
194.18
145.51
98.80
122.77
82.25
Net Current Assets
986.28
948.86
1,092.80
871.56
1,119.74
1,536.37
1,872.95
355.84
357.02
352.66
Total Assets
3,159.22
3,179.53
3,310.94
3,111.76
3,141.80
3,132.93
3,190.06
1,520.73
1,305.45
1,153.49

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
16.69
-85.09
-259.61
32.98
19.82
-327.77
-112.34
68.19
111.91
78.10
PBT
-61.67
-176.36
21.97
51.48
-48.21
-57.44
3,241.14
141.25
137.68
77.41
Adjustment
187.39
132.84
80.46
65.65
18.79
6.80
-3,207.66
53.31
39.65
35.57
Changes in Working Capital
-102.65
-29.36
-354.43
-69.78
53.58
-264.94
-146.67
-98.65
-34.16
-16.49
Cash after chg. in Working capital
23.07
-72.88
-252.00
47.35
24.15
-315.57
-113.20
95.91
143.16
96.49
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-6.38
-12.21
-7.62
-14.36
-4.34
-12.20
0.86
-27.72
-31.25
-18.39
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
50.40
202.81
102.40
-73.56
-35.91
-286.01
1,648.33
-127.87
-85.33
-52.34
Net Fixed Assets
-1.95
-20.93
-121.73
-327.70
-338.73
-139.02
-107.71
-135.60
154.89
-73.58
Net Investments
-3.55
349.28
134.15
147.92
374.24
-63.59
-889.36
17.40
42.09
-32.73
Others
55.90
-125.54
89.98
106.22
-71.42
-83.40
2,645.40
-9.67
-282.31
53.97
Cash from Financing Activity
-106.31
-81.30
191.23
-121.07
-62.30
-2.42
-881.13
59.23
-33.42
-50.95
Net Cash Inflow / Outflow
-39.21
36.42
34.01
-161.65
-78.40
-616.19
654.86
-0.46
-6.84
-25.19
Opening Cash & Equivalents
183.75
109.20
77.46
231.52
197.05
666.07
11.21
11.67
26.96
52.15
Closing Cash & Equivalent
150.91
183.75
109.20
77.46
231.52
197.05
666.07
11.21
20.13
26.96

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
335.11
344.18
370.38
362.05
358.85
371.69
380.95
116.88
104.93
95.48
ROA
-2.22%
-6.22%
1.03%
1.11%
-1.94%
-0.75%
108.06%
7.68%
8.82%
6.55%
ROE
-2.95%
-8.04%
1.28%
1.37%
-2.37%
-0.90%
136.04%
10.77%
11.92%
8.95%
ROCE
-1.47%
-5.60%
1.00%
2.12%
-1.49%
-1.77%
162.77%
13.42%
14.97%
9.29%
Fixed Asset Turnover
0.96
0.86
0.99
1.08
1.06
1.43
2.21
3.08
2.32
1.71
Receivable days
128.35
147.31
107.17
94.63
136.61
109.51
78.30
63.41
55.72
58.55
Inventory Days
142.36
166.52
163.63
138.14
121.57
93.93
73.33
60.67
59.32
62.03
Payable days
190.38
179.25
201.09
278.03
76.39
73.41
94.97
104.25
52.00
52.61
Cash Conversion Cycle
80.33
134.58
69.71
-45.27
181.78
130.03
56.65
19.82
63.05
67.97
Total Debt/Equity
0.09
0.12
0.13
0.04
0.07
0.08
0.06
0.09
0.04
0.03
Interest Cover
-1.72
-9.19
4.60
11.12
-5.25
-6.64
405.79
43.00
48.57
26.45

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Unichem Laboratories planning to consolidate generics formulations business in US market
    23rd Sep 2024, 12:58 PM

    The meeting of the Board of Directors of the Company scheduled to be held on September 30, 2024 to consider the same

    Read More
  • Unichem Laboratories gets VAI classification for Goa formulation facility
    10th Sep 2024, 15:26 PM

    Earlier, USFDA had conducted an inspection at Unichem Laboratories’ Goa formulation facility from July 08, 2024 to July 15, 2024

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.